Trials / Completed
CompletedNCT03673306
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
A Multicenter Retrospective Study on the Prognostic Impact of Pregnancy in Women With History of BRCA Mutated Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,732 (actual)
- Sponsor
- Jules Bordet Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The present study aims at refining the understanding of the effect of pregnancy on breast cancer outcomes in the specific population of BRCA mutated patients with known history of breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Clinical outcomes | Clinical outcomes |
Timeline
- Start date
- 2017-01-16
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2018-09-17
- Last updated
- 2024-12-13
- Results posted
- 2024-12-13
Locations
81 sites across 26 countries: United States, Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil, Canada, France, Georgia, Germany, India, Israel, Italy, Lebanon, Mexico, Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Switzerland
Source: ClinicalTrials.gov record NCT03673306. Inclusion in this directory is not an endorsement.